Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Surgical and pathological characteristics a

From: Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy

  CD0 group (n = 61) CD1/2 group (n = 44) CD3/4 group (n = 10) Total (n = 115) P Value
Surgical type      0.672
     Open 55 (90.2) 42 (95.5) 9 (90.0) 106 (92.2)  
     MIS 6 (9.8) 2 (4.5) 1 (10.0) 9 (7.8)  
Gastrectomy      0.219
     Subtotal 31 (50.8) 15 (34.1) 5 (50.0) 51 (44.3)  
     Total 30 (49.2) 29 (65.9) 5 (50.0) 64 (55.7)  
Surgical radicality      0.802
     Radical 37 (60.7) 29 (65.9) 7 (70.0) 73 (63.5)  
     Palliative 24 (39.3) 15 (34.1) 3 (30.0) 42 (36.5)  
Lymphadenectomy      0.504
     D2 47 (77.0) 31 (70.5) 8 (80.0) 86 (74.8)  
     D1 plus 13 (21.3) 10 (22.7) 1 (10.0) 24 (20.9)  
     D1 1 (1.6) 3 (6.8) 1 (10.0) 5 (4.3)  
Combined resection      0.592
     Yes 12 (19.7) 7 (15.9) 3 (30.0) 22 (19.1)  
     No 49 (80.3) 37 (84.1) 7 (70.0) 93 (80.9)  
EBLb (mL) 95 (28–300) 126 (30–609) 269 (50–640) 100 (28–640) 0.017
Transfusion      <0.001
     Yes 0 (0.0) 17 (38.6) 1 (10.0) 18 (15.7)  
     No 61 (100.0) 27 (61.4) 9 (90.0) 97 (84.3)  
Borrmann type      0.524
     I 6 (9.8) 2 (4.5) 2 (20.0) 10 (8.7)  
     II 12 (19.7) 10 (22.7) 1 (10.0) 23 (20.0)  
     III 32 (52.5) 20 (45.5) 6 (60.0) 58 (50.4)  
     IV 11 (18.0) 12 (27.3) 1 (10.0) 24 (20.9)  
Lauren type      0.569
     Intestinal 30 (49.2) 23 (52.3) 6 (60.0) 59 (51.3)  
     Diffuse 26 (42.6) 18 (40.9) 2 (20.0) 46 (40.0)  
     Mixed 5 (8.2) 3 (6.8) 2 (20.0) 10 (8.7)  
TNM Stage      0.846
     yp 0 4 (6.6) 1 (2.3) 1 (10.0) 6 (5.2)  
     yp Ia-Ib 14 (23.0) 7 (15.9) 1 (10.0) 22 (19.1)  
     yp IIa-IIb 6 (9.8) 6 (13.6) 2 (20.0) 14 (12.2)  
     yp IIIa-IIIc 15 (24.6) 15 (34.1) 3 (30.0) 33 (28.7)  
     yp IV 22 (36.1) 15 (34.1) 3 (30.0) 40 (34.8)  
  1. EBL, Estimated blood loss; MIS, Minimal invasive surgery
  2. aData are presented as number (percentage) unless indicated otherwise
  3. bData are presented as median (range)